Concepedia

Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

Paul Lephart, Michael A. Bachman, William LeBar, Scott McClellan, Karen Barron, Lee Schroeder, Duane W. Newton

Diagnostic Microbiology and Infectious Disease · 2020 · 50 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2

Elizabeth Smith, Ryhana Manji, Deborah Schron et al. · Journal of Clinical Microbiology · 2020 · 246 citations · Full text

, , +17

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2

Marie C. Smithgall, Ioana Scherberkova, Susan Whittier et al. · Journal of Clinical Virology · 2020 · 202 citations · Full text

, , +3

Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic

Femke Wolters, Jeroen van de Bovenkamp, Bart Van den Bosch et al. · Journal of Clinical Virology · 2020 · 158 citations · Full text

, , +7

Diagnostic Performance of Chest X-Ray for COVID-19 Pneumonia During the SARS-CoV-2 Pandemic in Lombardy, Italy

Simone Schiaffino, Stefania Tritella, Andrea Cozzi et al. · Journal of Thoracic Imaging · 2020 · 118 citations

, , +17

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection

Benoît Visseaux, Quentin Le Hingrat, Gilles Collin et al. · Journal of Clinical Microbiology · 2020 · 114 citations · Full text

, , +14